Skip to main content
. 2023 Mar 6;15(5):1300. doi: 10.3390/nu15051300

Table 2.

Ophthalmological variables at baseline and at the end of the study in patients treated with the DHA supplement and in controls.

Variables Control Group (n = 15) DHA Group (n = 19) Within-Group
p Value
Between-Group
p Value
Baseline End of Study Baseline End of Study Control Group DHA Group Baseline End of Study
K1, diopters 43.5 (3.0) 43.6 (3.1) 44.9 (2.9) 44.0 (2.8) 0.571 0.387 0.176 0.163
K2, diopters 47.0 (3.5) 47.1 (3.4) 48.8 (3.8) 48.8 (3.7) 0.221 0.779 0.155 0.174
Kmax, diopters 53.2 (6.0) 53.2 (5.8) 54.9 (5.6) 54.8 (5.6) 0.671 0.271 0.407 0.440
Km, diopters 45.1 (3.1) 45,2 (3.1) 46.8 (3.0) 46.8 (2.9) 0.299 0.409 0.147 0.145
Astigmatism axis, degrees 124.4 (52.7) 119.7 (58.4) 66.0 (63.6) 69.7 (60.8) 0.369 0.310 0.006 0.021
Astigmatism degree diopters 3.4 (1.6) 3.5 (1.7) 3.8 (2.7) 3.8 (2.7) 0.539 0.494 0.578 0.711
Asphericity coefficient (D)
Horizontal hemi-axis −0.4 (0.4) −0.4 (0.4) −0.7 (0.3) −0.7 (0.3) 0.612 0.119 0.022 0.015
Vertical hemi-axis −0.4 (0.3) −0.4 (0.4) −0.8 (0.3) −0.8 (0.3) 0.346 0.771 0.008 0.007
CAT, µm 489.8 (38.7) 491.6 (39.2) 469,3 (46.7) 470.3 (46.7) 0.147 0.318 0.172 0.157
CCT, µm 495.8 (37.2) 498.2 (37.6) 478.1 (44.6) 478.4 (44.7) 0.045 0.734 0.217 0.171
MCT, µm 470.4 (51.9) 470.7 (50.6) 459.8 (46.5) 461.0 (46.4) 0.830 0.252 0.541 0.568
CA, mm 2.4 (1.8) 2.4 (1.8) 2.2 (1.3) 2.3 (1.3) 0.111 0.528 0.675 0.900
IOP GAT, mmHg 10.8 (2.4) 11.9 (4.0) 11.5 (3.2) 10.3 (3.0) 0.214 0.052 0.373 0.192
IOP rebound, mmHg 10.4 (3.3) 10.8 (2.8) 10.6 (3.2) 9.9 (3.0) 0.672 0.371 0.839 0.381

K1: flat keratometry; K2: steep keratometry; Kmax: maximum keratometry; Km: mean keratometry; CAT: corneal apex thickness; CCT: central corneal thickness; MCT: minimum corneal thickness; CA: chromatic aberration; IOP: intraocular pressure; GAT: Goldmann applanation tonometry. Data expressed as mean and standard deviation (SD).